Press - MariMed

An Update on MariMed's COVID-19 Response

MariMed is monitoring the spread of COVID-19 in the U.S. and proactively working across each of our business units to minimize its impact on the supply chain. Our first priority is to ensure medical cannabis patients continue to have access to the medicine they need at a time when they may be especially vulnerable. While we have not yet experienced significant disruption to our core cannabis...